ANTONIO
MOLINA CARBALLO
PROFESOR TITULAR DE UNIVERSIDAD
Hospital Universitario San Cecilio
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (42)
2024
-
Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment
Antioxidants, Vol. 13, Núm. 1
2022
-
Dose-Dependent Effect of Melatonin on BAT Thermogenesis in Zücker Diabetic Fatty Rat: Future Clinical Implications for Obesity
Antioxidants, Vol. 11, Núm. 9
-
Protective effect of melatonin administration against sars-cov-2 infection: A systematic review
Current Issues in Molecular Biology, Vol. 44, Núm. 1
2021
-
Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications
Nutrients, Vol. 13, Núm. 1, pp. 1-32
2020
-
Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology
Journal of Child and Adolescent Psychopharmacology, Vol. 30, Núm. 3, pp. 177-188
-
Possible Protective Role of Melatonin in Pediatric Infectious Diseases and Neurodevelopmental Pathologies
Journal of Child Science, Vol. 10, Núm. 1, pp. 104-109
2019
-
Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids
Minerva Pediatrica, Vol. 71, Núm. 3, pp. 313-325
2018
-
Clinical Considerations Derived From the Administration of Melatonin to Children With Sleep Disorders
Pediatric Neurology, Vol. 78, pp. 61-69
2017
-
Analysis of Different Melatonin Secretion Patterns in Children with Sleep Disorders: Melatonin Secretion Patterns in Children
Journal of Child Neurology, Vol. 32, Núm. 12, pp. 1000-1008
-
BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology
Psychopharmacology, Vol. 234, Núm. 2, pp. 267-279
-
Melatonin treatment reduces oxidative damage and normalizes plasma pro-inflammatory cytokines in patients suffering from charcot-marie-tooth neuropathy: A pilot study in three children
Molecules, Vol. 22, Núm. 10
-
Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants
British Journal of Nutrition, Vol. 117, Núm. 7, pp. 994-1000
2016
-
Treatments and compositions for attention deficit hyperactivity disorder: A patent review
Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 7, pp. 799-814
2014
-
Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology
Psychopharmacology, Vol. 231, Núm. 17, pp. 3635-3645
-
Epidemiology of imported bilharzia: Prophylactic and treatment options for children
Schistosomiasis: Epidemiology, Diagnosis and Treatment (Nova Science Publishers, Inc.), pp. 171-185
-
Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes
International Journal of Molecular Sciences, Vol. 15, Núm. 9, pp. 17115-17129
2013
-
Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD
Journal of Psychiatric Research, Vol. 47, Núm. 3, pp. 377-383
2011
-
Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy
Clinical Biochemistry, Vol. 44, Núm. 10-11, pp. 853-858
-
Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy
Journal of Pineal Research, Vol. 50, Núm. 2, pp. 192-196
-
Psychosocial dwarfism: Psychopathological aspects and putative neuroendocrine markers
Psychiatry Research, Vol. 188, Núm. 1, pp. 96-101